| RS2485562923 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2485562982 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tumor predisposition syndrome 3 |
| RS2485575117 |
POT1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Tumor predisposition syndrome 3 |
| RS2485575164 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2485575173 |
POT1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2485575178 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2485577175 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485577477 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485617639 |
WEE2
|
Health Risk |
Pathogenic |
— |
| RS2485626958 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2485654139 |
RELN
|
Health Risk |
Likely pathogenic |
Norman-Roberts syndrome, Norman-Roberts syndrome |
| RS2485666331 |
PPP1R35
|
Health Risk |
Pathogenic |
Progressive microcephaly, Progressive microcephaly |
| RS2485689198 |
RELN
|
Health Risk |
Likely pathogenic |
Norman-Roberts syndrome, Norman-Roberts syndrome |
| RS2485692231 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2485697689 |
CAMK2B
|
Health Risk |
Likely pathogenic |
— |
| RS2485717743 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2485717851 |
RELN
|
Health Risk |
Likely pathogenic |
RELN-related disorder, RELN-related disorder |
| RS2485729429 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia type II, Neonatal intrahepatic cholestasis due to citrin deficiency |
| RS2485729829 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485736654 |
SLC25A13
|
Health Risk |
Likely pathogenic |
— |
| RS2485736833 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485738685 |
KMT2C
|
Health Risk |
Pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2485749454 |
ATP6V0A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular acidosis, distal |
| RS2485755924 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2485760600 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2485780102 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Papillary renal cell carcinoma type 1 |
| RS2485789680 |
KMT2C
|
Health Risk |
Likely pathogenic |
Tip-toe gait, Tip-toe gait |
| RS2485791673 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485791702 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485792452 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485792717 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485792804 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485796243 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485806968 |
ATP6V0A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive distal renal tubular acidosis, Autosomal recessive distal renal tubular acidosis |
| RS2485819162 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485819209 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485821259 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485823613 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2485829669 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485835065 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2485837844 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485838385 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485838622 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485839244 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485846446 |
KMT2C
|
Health Risk |
Pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2485855763 |
ATP6V0A4
|
Health Risk |
Likely pathogenic |
Renal tubular acidosis, distal |
| RS2485855824 |
ATP6V0A4
|
Health Risk |
Pathogenic |
Renal tubular acidosis, distal |
| RS2485855918 |
ATP6V0A4
|
Health Risk |
Likely pathogenic |
Renal tubular acidosis, distal |
| RS2485876010 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS2485880890 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2485880908 |
XRCC2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2485881102 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2485881210 |
XRCC2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2485881405 |
XRCC2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2485881817 |
XRCC2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2485881992 |
XRCC2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2485882087 |
XRCC2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2485884567 |
RMND1
|
Health Risk |
Pathogenic |
— |
| RS2485893388 |
ELN
|
Health Risk |
Likely pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2485894223 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485894532 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485894614 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485894721 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485894793 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485894796 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485901377 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2485901451 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2485915480 |
RMND1
|
Health Risk |
Pathogenic |
— |
| RS2485915620 |
XRCC2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2485915656 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2485922583 |
CNTNAP2
|
Health Risk |
Likely pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2485922676 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2485923443 |
CNTNAP2
|
Health Risk |
Likely pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2485939911 |
RMND1
|
Health Risk |
Pathogenic |
— |
| RS2485959310 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS2485962955 |
RMND1
|
Health Risk |
Pathogenic |
— |
| RS2485967112 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2485973971 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485974086 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485974231 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485974252 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2485974254 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2485979609 |
AASS
|
Health Risk |
Likely pathogenic |
Hyperlysinemia, Hyperlysinemia |
| RS2485982699 |
CUX1
|
Health Risk |
Likely pathogenic |
— |
| RS2485984699 |
CCM2
|
Health Risk |
Likely pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS2485984746 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS2485984791 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS2485985621 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS2485985882 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS2485995124 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2485999842 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2486000512 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2486000547 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2486000773 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2486001146 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2486001403 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2486001553 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2486003255 |
KCNH2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2486003476 |
KCNH2
|
Health Risk |
Pathogenic |
— |
| RS2486004001 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |